Why Richard Pazdur taking over the FDA’s drug division is good for patients — and drug companies

statnews.com/2025/11/11/richard-pazdur-cder-head-win-for-patients-drug-companies

Naming veteran regulator Richard Pazdur to head the Food and Drug Administration’s Center for Drug Evaluation and Research is fantastic news for patients, drug companies, and anyone who cares about a rigorous, data-based FDA.
It is the best news the FDA, which has been going through a…

This story appeared on statnews.com, 2025-11-13 10:45:07.050000.
The Entire Business World on a Single Page. Free to Use →